2. Apoptosis Immunology/Inflammation Epigenetics PI3K/Akt/mTOR Protein Tyrosine Kinase/RTK JAK/STAT Signaling Stem Cell/Wnt Neuronal Signaling Membrane Transporter/Ion Channel NF-κB Metabolic Enzyme/Protease Cell Cycle/DNA Damage Vitamin D Related/Nuclear Receptor
  3. Apoptosis Pyroptosis AMPK Bcl-2 Family JAK STAT Calcium Channel Interleukin Related TNF Receptor SOD Reactive Oxygen Species PPAR
  4. Calenduloside E

Calenduloside E 是一种五环三萜皂苷，可以从楤木的树皮和根中提取得到，具有抗炎和抗凋亡活性。Calenduloside E 通过调节巨噬细胞极化减轻动脉粥样硬化，调节 AMPK-SIRT3 通路改善线粒体功能，减轻急性肝损伤。此外，Calenduloside E 促进 L 型钙通道 (Calcium Channel) 与 Bcl-2 相关凋亡 (apoptosis) 基因相互作用，抑制钙超载，减轻心肌缺血/再灌注损伤。Calenduloside E 还通过调节热休克依赖途径改善非酒精性脂肪肝，抑制 ROS 介导的 JAK1-STAT3 通路减轻细胞炎症反应。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

Calenduloside E Chemical Structure

Calenduloside E Chemical Structure

CAS No. : 26020-14-4

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥1400
In-stock
5 mg ￥3500
In-stock
10 mg ￥5000
In-stock
25 mg 现货 询价
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

Calenduloside E 相关抗体

Top Publications Citing Use of Products

MCE 顾客使用本产品发表的 1 篇科研文献

查看 AMPK 亚型特异性产品:

查看所有亚型
NUAK1 NUAK2 AMPK AMPK α1β1γ1 AMPK α2β1γ1 AMPK α1β2γ1 AMPK α2β2γ1

查看 Bcl-2 Family 亚型特异性产品:

查看所有亚型
Bcl-2 Bcl-xL Bcl-W Mcl-1 Bfl-1 Bcl-B Bax Bak Bim

查看 JAK 亚型特异性产品:

查看所有亚型
JAK1 JAK2 JAK3 Tyk2 JAK

查看 STAT 亚型特异性产品:

查看所有亚型
STAT3 STAT5 STAT6 STAT1

查看 Calcium Channel 亚型特异性产品:

查看所有亚型
N-type calcium channel L-type calcium channel P/Q-type calcium channel T-type calcium channel Calcium Channel

查看 Interleukin Related 亚型特异性产品:

查看所有亚型
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22

查看 TNF Receptor 亚型特异性产品:

查看所有亚型
TNFRSF1A/CD120a TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

查看 PPAR 亚型特异性产品:

查看所有亚型
PPARα PPARβ/δ PPARγ PPAR PPARδ

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Calenduloside E is a pentacyclic triterpenoid saponin that can be extracted from the bark and roots of Aralia ovata, and has anti-inflammatory and anti-apoptotic activities. Calenduloside E alleviates atherosclerosis by regulating macrophage polarization, improves mitochondrial function by regulating the AMPK-SIRT3 pathway, and alleviates acute liver injury. In addition, Calenduloside E promotes the interaction between L-type calcium channels and Bcl-2 related apoptosis genes, inhibits calcium overload, and alleviates myocardial ischemia/reperfusion injury. Calenduloside E also improves non-alcoholic fatty liver disease by regulating heat shock-dependent pathways, and inhibits ROS mediated JAK1-STAT3 pathways to reduce cellular inflammatory responses[1][2][3][4][5][6].

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
HCT-116 IC50
18 μM
Compound: OAG
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTT assay
10.1039/C5MD00502G
MCF7 IC50
11.33 μM
Compound: OAG
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
10.1039/C5MD00502G
MOLT-4 IC50
13.34 μM
Compound: OAG
Cytotoxicity against human MOLT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MOLT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
10.1039/C5MD00502G
NCI-H460 IC50
6 μM
Compound: 18
Cytotoxicity against human NCI-H460 cells incubated for 72 hrs by cell-titer 96 aqueous non-radioactive cell proliferation assay
Cytotoxicity against human NCI-H460 cells incubated for 72 hrs by cell-titer 96 aqueous non-radioactive cell proliferation assay
[PMID: 26287548]
SK-BR-3 IC50
11.88 μM
Compound: OAG
Cytotoxicity against human SKBR3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human SKBR3 cells assessed as reduction in cell viability after 72 hrs by MTT assay
10.1039/C5MD00502G
体外研究
(In Vitro)

Calenduloside E (1.25 μg/mL; 24 h) 抑制糖酵解介导的 M1 巨噬细胞极化[2]。
Calenduloside E (1 μM; 2 h) 可缓解 LPS (HY-D1056)/D-galn 诱导的 AML12 和 LX2 细胞损伤和 AMPK-SIRT3 信号通路蛋白表达[3]。
Calenduloside E (0-16 μM; 24 h) 抑制脂质混合物刺激 AML-12 细胞中炎性小体激活和 AML-12 细胞的焦亡 (Pyroptosis)[5]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Calenduloside E 相关抗体:

Western Blot Analysis[2]

Cell Line: ox-LDL-induced M1 macrophages
Concentration: 1.25 μg/mL
Incubation Time: 24 h
Result: Reduced the levels of IL-1 β, IL-6, PFKFB3, GLUT1 and LDHA.

Western Blot Analysis[3]

Cell Line: LPS/ d-galn-induced AML12 and LX2 cells
Concentration: 1 μM
Incubation Time: 2 h
Result: Reduced ROS and JC-1 levels, as well as cell apoptosis.

Immunofluorescence[5]

Cell Line: AML-12 cells stimulated with lipid mixture
Concentration: 2, 4, 8 and 16 μM
Incubation Time: 24 h
Result: Inhibited the increased expression of NLRP3, Caspase-1 p20, and IL-1β.
体内研究
(In Vivo)

Calenduloside E (11 mg/kg; i.g.; 每天 1 次连续 16 周) 减小 ApoE-/- 小鼠动脉粥样硬化斑块大小，增强斑块稳定性，并减少炎症反应[2]。
Calenduloside E (15 和 30 mg/kg; i.g.; 每天 1 次连续 7 天) 抑制 LPS (HY-D1056) 和 D-GalN 诱导的急性肝损伤小鼠肝细胞凋亡，降低小鼠氧化应激和免疫炎症[3]。
Calenduloside E (7.5-30 mg/kg; i.g.; 每天 1 次连续 3 天) 恢复了成年大鼠心室肌细胞 (ARVMs) 的肌节收缩和钙瞬态[4]。
Calenduloside E (5 和 10 mg/kg; i.g.; 每天 1 次连续 4 周) 改善了非酒精性脂肪肝模型小鼠的肝损伤、脂质积累和促纤维化表型并抑制小鼠肝脏炎性体活化和焦亡 (pyroptosis)[5]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: HFD-fed ApoE-/- mice[2]
Dosage: 11 mg/kg
Administration: i.g.；Once a day for 16 weeks
Result: Reduced the levels of IL-1β, IL-6, TNF-α, and monocyte chemoattractant protein-1 (MCP-1) in the serum of ApoE-/- mice.
Animal Model: LPS (HY-D1056)/dGalN-induced acute liver injury in mice[3]
Dosage: 15 and 30 mg/kg
Administration: i.g.; 1 time per day for 7 consecutive days
Result: Improved hepatocyte infiltration and reduced hepatocyte necrosis and shrinkage.
Reduced hepatocyte ROS levels and serum MDA levels, and increased GSH-Px and SOD levels.
Animal Model: Rat Model of MI/R Injury[4]
Dosage: 7.5, 15 and 30 mg/kg
Administration: i.g.; 1 time per day for 3 consecutive days
Result: Myocardial infarction area/risk area decreased to 53%, 38% and 43% respectively.
Restored the expression of calcium-regulating proteins, including calcium transporters (SERCA, a1C, RyR2, and NCX) to normal levels.
Animal Model: Establishment of NAFLD model in apoE-/- mice by western diet[5]
Dosage: 5 and 10 mg/kg
Administration: i.g.; 1 time per day for 4 weeks
Result: Reduced the expression of TNF-α, MCP-1, CCL2, Ly6c and cd68 in the liver.
Reversed the upregulation of lipogenic genes FASN, Srebpf, ACC and PPARγ and lipid uptake gene cd36.
Reduced the expression of NLRP3, pNLRC4, NLRC4, cleaved GSDMD, cleaved Caspase1 and IL-1β.
分子量

632.82

Formula

C36H56O9
CAS 号
性状

固体

颜色

White to off-white

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
细胞实验： 

DMSO 中的溶解度 : 100 mg/mL (158.02 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响，请使用新开封的 DMSO)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.5802 mL 7.9011 mL 15.8023 mL
5 mM 0.3160 mL 1.5802 mL 3.1605 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C储存时，请在6个月内使用，-20°C储存时，请在1个月内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验：

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用；
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂： 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (3.95 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL（饱和度未知）的澄清溶液。

    以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中，混合均匀。

    2 g SBE-β-CD（磺丁基醚 β-环糊精）粉末定容于 10 mL 的生理盐水中，完全溶解至澄清透明。
  • 方案 二

    请依序添加每种溶剂： 10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (3.95 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL（饱和度未知）的澄清溶液，此方案实验周期在半个月以上的动物实验酌情使用。

    以 1 mL 工作液为例，取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

动物溶解方案计算器
请输入动物实验的基本信息：

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

只
由于实验过程有损耗，建议您多配一只动物的量
请输入您的动物体内配方组成：
%
DMSO +
% 
+
%
Tween-80 +
%
Saline
如果您的动物是免疫缺陷鼠或者体弱鼠，建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
方案所需 助溶剂 包括：DMSO， ，均可在 MCE 网站选购。 ，Tween 80，均可在 MCE 网站选购。
计算结果
工作液所需浓度 : mg/mL
储备液配制方法 : mg 药物溶于 μL  DMSO（母液浓度为 mg/mL）。
您所需的储备液浓度超过该产品的实测溶解度，以下方案仅供参考，如有需要，请与 MCE 中国技术支持联系。
动物实验体内工作液的配制方法 : 取 μL DMSO 储备液，加入 μL 。 μL ，混合均匀至澄清，再加 μL Tween 80，混合均匀至澄清，再加 μL 生理盐水。
连续给药周期超过半月以上，请谨慎选择该方案。
请确保第一步储备液溶解至澄清状态，从左到右依次添加助溶剂。您可采用超声加热 （超声清洗仪，建议频次 20-40 kHz），涡旋吹打等方式辅助溶解。
纯度 & 产品资料

纯度: 99.07%

COA (291 KB) HNMR (286 KB) LCMS (87 KB)

产品使用指南 (1538 KB)
参考文献

Calenduloside E 相关分类

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C储存时，请在6个月内使用，-20°C储存时，请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.5802 mL 7.9011 mL 15.8023 mL 39.5057 mL
5 mM 0.3160 mL 1.5802 mL 3.1605 mL 7.9011 mL
10 mM 0.1580 mL 0.7901 mL 1.5802 mL 3.9506 mL
15 mM 0.1053 mL 0.5267 mL 1.0535 mL 2.6337 mL
20 mM 0.0790 mL 0.3951 mL 0.7901 mL 1.9753 mL
25 mM 0.0632 mL 0.3160 mL 0.6321 mL 1.5802 mL
30 mM 0.0527 mL 0.2634 mL 0.5267 mL 1.3169 mL
40 mM 0.0395 mL 0.1975 mL 0.3951 mL 0.9876 mL
50 mM 0.0316 mL 0.1580 mL 0.3160 mL 0.7901 mL
60 mM 0.0263 mL 0.1317 mL 0.2634 mL 0.6584 mL
80 mM 0.0198 mL 0.0988 mL 0.1975 mL 0.4938 mL
100 mM 0.0158 mL 0.0790 mL 0.1580 mL 0.3951 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Calenduloside E26020-14-4ApoptosisPyroptosisAMPKBcl-2 FamilyJAKSTATCalcium ChannelInterleukin RelatedTNF ReceptorSODReactive Oxygen SpeciesPPARAMP-activated protein kinaseJanus kinaseCa2+ channelsCa channelsILTumor Necrosis Factor ReceptorTNFRSuperoxide DismutasePeroxisome proliferator-activated receptorsInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Calenduloside E
目录号：
HY-N6850
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z